ALXP
ALCRB
Market cap105mUSD
Oct 28, Last price
5.13EUR
1D
0.79%
1Q
-28.05%
Jan 2017
-39.15%
IPO
-58.70%
Name
Carbios SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Carbios SAS, a French green chemistry firm, specializes in developing industrial bioprocesses for the biodegradation and biorecycling of polymers. Its core innovations encompass EVANESTO, an enzymatic biodegradation solution tailored for single-use plastics derived from polylactic acid (PLA), and a separate enzymatic process for recycling polyethylene terephthalate (PET). Additionally, Carbios offers PLA, which is a biosourced and biodegradable plastic polymer, and converts plastic waste into new plastic materials. The company also distributes its products globally. Carbios SAS maintains a development agreement with Novozymes, focusing on the production of enzymes essential for recycling PET plastics and fibers. Founded in 2011, the company is headquartered in Saint-Beauzire, France.
Related entities
Subsidiaries
CARBIOS 54
Key people
Antoine Trillot
Chief Administrative and Financial Officer · since 2024
Mathieu Berthoud
Senior Vice President - Business Development, Feedstock Recycling · since 2023
Benedicte Garbil
Senior Vice President - Sustainability and Communication · since 2023
Tommy Maussin
Chief Marketing Officer · since 2024
Alain Marty
Chief Scientific Officer · since 2015
Lionel Arras
Director of Industrial Development · since 2023
Sophie Balmary
Director of Human Resources and Legal Affairs · since 2023
Delphine Denoize
Public Funding and Regulation Director · since 2023
Stephane Ferreira
Chief Biorecycling Business Officer · since 2023
Lise Lucchesi
Director Of Intellectual Property · since 2021
Vincent Kamel
Chief Executive Officer, Director · since 2025
Laurent Schmitt
Director, Representative of BOLD, Business Opportunities for L'Oreal Development · since 2021
Nicolas Seeboth
Director, Representative of Michelin Ventures · since 2021
Alen Vukic
Director, Representative of Copernicus Wealth Management · since 2022
Karine Auclair
Independent Director · since 2023
Mateus Lopes
Independent Director · since 2023
Isabelle Parize
Independent Chairman of the Board · since 2025
Independent Director · since 2024
Headquarters & legal address
8 RUE DE LA GROLIERE
SITE DE CATAROUX
CLERMONT-FERRAND 63100
FR
SITE DE CATAROUX
CLERMONT-FERRAND 63100
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||